OKLAHOMA CITY, OK--(Marketwire - Feb 4, 2013) - On February 1, 2013, a class action lawsuit was filed in the United States District Court for the Southern District of New York against Keryx Biopharmaceuticals, Inc. (
Plaintiff seeks to recover damages on behalf of all Keryx Biopharmaceuticals, Inc. shareholders who purchased common stock during the Class Period and are therefore a member of the Class as described above. You may move the Court no later than Tuesday, April 2, 2013 to serve as a lead plaintiff for the entire Class. However, in order to do so, you must meet certain legal requirements pursuant to the Private Securities Litigation Reform Act of 1995.
If you wish to discuss this action, obtain further information and participate in this or any other securities litigation, or should you have any questions or concerns regarding this notice or preservation of your rights, please contact: